Leadership Team

Chief Executive Officer

Andrew Sleight, PhD

Know more

Chief Financial Officer

Fernando Cunha

Know more

Medical Director

Eduardo Schiffrin, MD

Know more

Dr. Sleight joined AB2 Bio in 2013 bringing with him over 25 years of experience in the Pharmaceutical Industry including 21 years with Roche where he was Global Therapeutic Area Head of Neuroscience. While at Roche, he also held the positions of Chairman of the Neuroscience Strategy Committee and Global Head of Business Development for Vascular and Metabolic Therapeutic Area. Dr. Sleight holds a B.Sc from the University of Bath, a Ph.D. from the University of Nottingham and a Post-Doctoral Diploma from Stanford University.

Mr. Cunha has several years of experience in Finance, Controlling, Tax and related matters. His career began with BDO where he held various positions in Switzerland and Australia. In 2009, he joined AC Immune SA in Lausanne, Switzerland as Head of Accounting and Finance Controlling and then Head of Financial Operations. Prior to joining AB2 Bio in September 2014, Mr. Cunha was Manager at KPMG Switzerland in the Business and Outsourcing Services department. Mr. Cunha is a Swiss Certified Expert for Finance and Controlling.

Dr. Schiffrin obtained his medical degree from La Plata University, Argentina, and was a research fellow at Harvard University where he studied mucosal immunology. He is a specialist in human pathology and inflammatory and immunological diseases. Before joining AB2 Bio he was a Medical Director for Nestlé Global Research and has been involved in the clinical development of multiple medical products treating inflammatory diseases and allergies.